Iridex IRIX
NASDAQ IRIX
$0.76 -0.02 (-2.30%)
At close: Aug 20, 2026 · 1:09 PM UTC

Iridex (IRIX) Cash from Discontinued Operations (2011 - 2012)

Iridex (IRIX) posted quarterly Cash from Discontinued Operations of 148000.0 for Q4 2012, down 16.38% year-over-year from 177000.0 in Q4 2011, and up 4.23% quarter-over-quarter from 142000.0 in Q3 2012.

Iridex (IRIX) Cash from Discontinued Operations (2011 - 2012) Analysis & Trends

Iridex's Cash from Discontinued Operations history runs 2 years deep, the most recent figure standing at 148000.0 for Q4 2012.

  • In Q4 2012, Cash from Discontinued Operations fell 16.38% year-over-year to 148000.0; the TTM figure through Sep 2013 stood at 148000.0 (down 79.56% YoY), while the FY2012 annual figure was 695000.0, down 12.8% from the prior year.
  • Cash from Discontinued Operations for Q4 2012 stood at 148000.0, up from 142000.0 in the prior quarter.
  • The five-year high for Cash from Discontinued Operations was 836000.0 in Q2 2011, with the low at 264000.0 in Q3 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Abbott Laboratories 199.07 Bn 193.46 Bn 7.27 Bn -
2 Stryker 127.90 Bn 124.43 Bn 4.50 Bn -
3 Medtronic 118.84 Bn 109.62 Bn 6.41 Bn -
4 Boston Scientific 73.33 Bn 72.79 Bn 3.85 Bn -
5 Edwards Lifesciences 51.93 Bn 47.68 Bn 1.35 Bn -
6 Dexcom 34.46 Bn 32.51 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.91 Bn 31.81 Bn 2.18 Bn -
8 Koninklijke Philips 26.36 Bn 23.04 Bn 4.55 Bn -
9 Steris 23.12 Bn 22.64 Bn 684.20 Mn -
10 Iridex 13.32 Mn 8.64 Mn 4.30 Mn -

Historic Data

Download Data
DateValue
Dec 29, 2012 148,000.00
Dec 29, 2012 148,000.00
Sep 29, 2012 142,000.00
Sep 29, 2012 142,000.00
Jun 30, 2012 604,000.00
Jun 30, 2012 604,000.00
Mar 31, 2012 -199,000.00
Mar 31, 2012 -199,000.00
Dec 31, 2011 177,000.00
Dec 31, 2011 177,000.00
Oct 1, 2011 48,000.00
Oct 1, 2011 48,000.00
Jul 2, 2011 -264,000.00
Jul 2, 2011 -264,000.00
Apr 2, 2011 836,000.00
Apr 2, 2011 836,000.00